Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

73.00
-2.4600-3.26%
Post-market: 73.000.00000.00%19:30 EDT
Volume:1.21M
Turnover:88.82M
Market Cap:3.20B
PE:-67.44
High:75.84
Open:75.84
Low:72.94
Close:75.46
52wk High:91.53
52wk Low:53.89
Shares:43.88M
Float Shares:35.64M
Volume Ratio:1.15
T/O Rate:3.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.24
PE(LYR):-45.91

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Yesterday

Tarsus Pharmaceuticals to Present 11 Abstracts at American Academy of Optometry Annual Meeting

Reuters
·
Sep 29

Tarsus Pharmaceuticals Price Target Announced at $116.00/Share by Goldman Sachs

Dow Jones
·
Sep 24

Tarsus Pharmaceuticals (TARS) Receives a Buy from Goldman Sachs

TIPRANKS
·
Sep 24

Tarsus Director William J. Link Reports Disposal of Common Shares Worth $977,707.22

Reuters
·
Sep 18

Tarsus Pharmaceuticals Price Target Announced at $110.00/Share by Barclays

Dow Jones
·
Sep 16

Tarsus Pharmaceuticals, Inc. : Barclays Reinstates Coverage with Overweight Rating; Price Target $110

THOMSON REUTERS
·
Sep 16

Q32 Bio Names José Trevejo Chief Medical Officer

Reuters
·
Sep 14

Tarsus Pharmaceuticals Completes Alkeus Retinal Therapy Acquisition

TIPRANKS
·
Sep 11

Tarsus COO Neervannan Seshadri Sells 4,564 Shares Worth $387,940

Reuters
·
Sep 10

Tarsus Pharmaceuticals is Maintained at Buy by Jefferies

Dow Jones
·
Sep 09

Tarsus Pharmaceuticals price target raised to $105 from $88 at Jefferies

TIPRANKS
·
Sep 09

Dennis Ding Reiterates Buy on Tarsus, Highlighting Robust Xdemvy Trends, Conservative 2026 Guidance, and Attractive Valuation Backed by Late-Stage Pipeline

TIPRANKS
·
Sep 09

Tarsus Pharmaceuticals Closes Acquisition of Alkeus Pharmaceuticals

MT Newswires Live
·
Sep 04

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

THOMSON REUTERS
·
Sep 04

Tarsus CMO Elizabeth Yeu Disposes of Common Shares Worth $787,879.86

Reuters
·
Sep 04

Tarsus Pharmaceuticals to Attend Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Tarsus to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

Tarsus Pharmaceuticals (TARS) Shares Just Moved, What Is Behind The Attention?

Simply Wall St.
·
Aug 18

Tarsus Pharmaceuticals Price Target Raised to $100.00/Share from $97.00 by Oppenheimer

Dow Jones
·
Aug 12